[CYCC] QoQ Quarter Result on 31-Dec-2009 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
29-Mar-2010
Financial Year
2009
Quarter
31-Dec-2009 [#Q4]
Profit Trend
QoQ- -38.83%
YoY- 45.40%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Revenue 159 119 271 187 230 266 228 -21.34%
PBT -3,950 -4,163 -5,244 -4,489 -3,329 -7,278 -5,421 -19.01%
Tax -143 -230 -133 -152 -205 -233 -358 -45.73%
NP -3,807 -3,933 -5,111 -4,337 -3,124 -7,045 -5,063 -17.29%
Tax Rate - - - - - - - -
Total Cost 3,966 4,052 5,382 4,524 3,354 7,311 5,291 -17.46%
Ratio Analysis
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
NP Margin -2,394.34 -3,305.04 -1,885.98 -2,319.25 -1,358.26 -2,648.50 -2,220.61 5.14%
Per Share
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
EPS -172.72 -180.70 -270.70 -229.70 -226.51 -579.26 -416.30 -44.34%
EPS Diluted -172.72 -180.70 -270.70 -229.70 -226.51 -579.26 -416.30 -44.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.